Skip to main content
Erschienen in: Journal of Endocrinological Investigation 12/2015

01.12.2015 | Original Article

The endocrine disruptor cadmium alters human osteoblast-like Saos-2 cells homeostasis in vitro by alteration of Wnt/β-catenin pathway and activation of caspases

verfasst von: V. Papa, V. M. Bimonte, F. Wannenes, A. S. D’Abusco, S. Fittipaldi, R. Scandurra, L. Politi, C. Crescioli, A. Lenzi, L. Di Luigi, S. Migliaccio

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 12/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The pollutant Cadmium (Cd) is widespread in the environment and causes alterations of human health by acting as an endocrine disruptor. Bone tissue seems to be a crucial target of Cd contamination. Indeed, we have previously demonstrated that this endocrine disruptor induces osteoblast apoptosis and necrosis. Thus, aim of this study was to further evaluate the effect of Cd on osteoblasts homeostasis, investigating potential modification of the Wnt/β-catenin intracellular pathway, the intracellular process involved in programmed cellular death and the cytoskeletal alterations.

Material and methods

To this purpose, human osteoblastic Saos-2 cells, a human osteosarcoma osteoblast-like cell line, were cultured and treated with Cd.

Results

Osteoblastic cells were treated for 6 h with 10μM Cd, which induced nuclear translocation of β-catenin and increased expression of Wnt/β-catenin target genes. Longer exposure to the same Cd concentration induced osteoblastic cell apoptosis. To better characterize the intracellular events involved in these Cd-induced alterations, we evaluated the effect of Cd exposure on actin filaments and proteins associated to cytoskeletal actin, characterized by the presence of LIM domains. Long (15, 24 h) exposure of osteoblasts to Cd reduced LIM proteins expression and induced actin filaments destruction and a significant caspase-3 activation after 24 h. In addition, to prove that Cd induces osteoblastic cells apoptosis after long exposure, we performed TUNEL assay which demonstrated increase of cell apoptosis after 24 h.

Conclusion

In conclusion, our study shows that osteoblasts exposed to Cd for short intervals of time demonstrated an increase in cell proliferation through a Wnt/β-catenin dependent mechanism, likely as a compensatory mechanism in response to cell injury. Longer exposure to the same Cd concentration induced cells apoptosis through cytoskeleton disruption-mediated mechanisms and caspase activation.
Literatur
1.
Zurück zum Zitat Adams SV, Quraishi SM, Shafer MM, Passarelli MN, Freney EP, Chlebowski RT, Luo J, Meliker JR, Mu L, Neuhouser ML, Newcomb PA (2014) Dietary cadmium exposure and risk of breast, endometrial, and ovarian cancer in the Women’s Health Initiative. Environ Health Perspect 122(6):594–600PubMedCentralPubMed Adams SV, Quraishi SM, Shafer MM, Passarelli MN, Freney EP, Chlebowski RT, Luo J, Meliker JR, Mu L, Neuhouser ML, Newcomb PA (2014) Dietary cadmium exposure and risk of breast, endometrial, and ovarian cancer in the Women’s Health Initiative. Environ Health Perspect 122(6):594–600PubMedCentralPubMed
2.
Zurück zum Zitat Ponce E, Aquino NB, Louie MC (2013) Chronic cadmium exposure stimulates SDF-1 expression in an ERα dependent manner. PLoS One. 8(8): e72639. doi: 10.1371/journal.pone.0072639 Ponce E, Aquino NB, Louie MC (2013) Chronic cadmium exposure stimulates SDF-1 expression in an ERα dependent manner. PLoS One. 8(8): e72639. doi: 10.1371/journal.pone.0072639
3.
Zurück zum Zitat Jiménez-Ortega V, Cano Barquilla P, Fernández-Mateos P, Cardinali DP, Esquifino AI (2012) Cadmium as an endocrine disruptor: correlation with anterior pituitary redox and circadian clock mechanisms and prevention by melatonin. Free Radic Biol Med. 53(12):2287–97. doi:10.1016/j.freeradbiomed.2012.10.533 Jiménez-Ortega V, Cano Barquilla P, Fernández-Mateos P, Cardinali DP, Esquifino AI (2012) Cadmium as an endocrine disruptor: correlation with anterior pituitary redox and circadian clock mechanisms and prevention by melatonin. Free Radic Biol Med. 53(12):2287–97. doi:10.​1016/​j.​freeradbiomed.​2012.​10.​533
4.
Zurück zum Zitat Ali I, Penttinen-Damdimopoulou PE, Mäkelä SI, Berglund M, Stenius U, Akesson A, Håkansson H, Halldin K (2010) Estrogen-like effects of cadmium in vivo do not appear to be mediated via the classical estrogen receptor transcriptional pathway. Environ Health Perspect.118(10):1389–94. doi:10.1289/ehp.1001967 Ali I, Penttinen-Damdimopoulou PE, Mäkelä SI, Berglund M, Stenius U, Akesson A, Håkansson H, Halldin K (2010) Estrogen-like effects of cadmium in vivo do not appear to be mediated via the classical estrogen receptor transcriptional pathway. Environ Health Perspect.118(10):1389–94. doi:10.​1289/​ehp.​1001967
5.
Zurück zum Zitat Järup L, Alfvén T (2004) Low level cadmium exposure, renal and bone effects the OSCAR study. Biometals 17:505–509CrossRefPubMed Järup L, Alfvén T (2004) Low level cadmium exposure, renal and bone effects the OSCAR study. Biometals 17:505–509CrossRefPubMed
6.
10.
Zurück zum Zitat Brama M, Gnessi L, Basciani S, Cerulli N, Politi L, Spera G et al (2007) Cadmium induces mitogenic signaling in breast cancer cell by an ERalpha-dependent mechanism. Mol Cell Endocrinol 264:102–108CrossRefPubMed Brama M, Gnessi L, Basciani S, Cerulli N, Politi L, Spera G et al (2007) Cadmium induces mitogenic signaling in breast cancer cell by an ERalpha-dependent mechanism. Mol Cell Endocrinol 264:102–108CrossRefPubMed
11.
Zurück zum Zitat Papa V, Wannenes F, Crescioli C, Caporossi D, Lenzi A, Migliaccio S et al (2014) The environmental pollutant cadmium induces homeostasis alteration in muscle cells in vitro. J Endocrinol Invest 37(11):1073–1080CrossRefPubMed Papa V, Wannenes F, Crescioli C, Caporossi D, Lenzi A, Migliaccio S et al (2014) The environmental pollutant cadmium induces homeostasis alteration in muscle cells in vitro. J Endocrinol Invest 37(11):1073–1080CrossRefPubMed
12.
Zurück zum Zitat Nordberg M (2004) Environmental exposure and preventive measures in Sweden and EU. Biometals 17:589–592CrossRefPubMed Nordberg M (2004) Environmental exposure and preventive measures in Sweden and EU. Biometals 17:589–592CrossRefPubMed
13.
14.
Zurück zum Zitat Brama M, Politi L, Santini P, Migliaccio S, Scandurra R (2012) Cadmium-induced apoptosis and necrosis in human osteoblasts: role of caspases and mitogen-activated protein kinases pathways. J Endocrinol Invest 35(2):198–208. doi:10.3275/7801 PubMed Brama M, Politi L, Santini P, Migliaccio S, Scandurra R (2012) Cadmium-induced apoptosis and necrosis in human osteoblasts: role of caspases and mitogen-activated protein kinases pathways. J Endocrinol Invest 35(2):198–208. doi:10.​3275/​7801 PubMed
15.
Zurück zum Zitat Chen X, Zhu G, Gu S, Jin T, Shao C (2009) Effect of cadmium on osteoblasts and osteoclasts in vitro. Environ Toxicol Pharmacol 28:232–236CrossRefPubMed Chen X, Zhu G, Gu S, Jin T, Shao C (2009) Effect of cadmium on osteoblasts and osteoclasts in vitro. Environ Toxicol Pharmacol 28:232–236CrossRefPubMed
16.
Zurück zum Zitat Kostenuik PJ (2005) Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength. Curr Opin Pharmacol 5:618–625CrossRefPubMed Kostenuik PJ (2005) Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength. Curr Opin Pharmacol 5:618–625CrossRefPubMed
17.
Zurück zum Zitat Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T et al (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165–176CrossRefPubMed Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T et al (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165–176CrossRefPubMed
18.
Zurück zum Zitat Coonse KG, Coonts AJ, Morrison EV, Heggland SJ (2007) Cadmium induces apoptosis in the human osteoblast-like cell line Saos-2. J Toxicol Environ Health A 70:575–581CrossRefPubMed Coonse KG, Coonts AJ, Morrison EV, Heggland SJ (2007) Cadmium induces apoptosis in the human osteoblast-like cell line Saos-2. J Toxicol Environ Health A 70:575–581CrossRefPubMed
19.
Zurück zum Zitat Robertson JD, Orrenius S (2000) Molecular mechanisms of apoptosis induced by cytotoxic chemicals. Crit Rev Toxicol 30:609–627CrossRefPubMed Robertson JD, Orrenius S (2000) Molecular mechanisms of apoptosis induced by cytotoxic chemicals. Crit Rev Toxicol 30:609–627CrossRefPubMed
20.
Zurück zum Zitat D’Sa-Eipper C, Leonard JR, Putcha G, Zheng TS, Flavell RA, Rakic P, Kuida K, Roth KA (2000) DNA damage-induced neural precursorcell apoptosis requires p53 and caspase 9 but neither Bax nor caspase 3. Development 128:137–146 D’Sa-Eipper C, Leonard JR, Putcha G, Zheng TS, Flavell RA, Rakic P, Kuida K, Roth KA (2000) DNA damage-induced neural precursorcell apoptosis requires p53 and caspase 9 but neither Bax nor caspase 3. Development 128:137–146
21.
22.
Zurück zum Zitat Wang Z, Templeton DM (1996) Cellular factors mediate cadmium dependent actin depolymerisation. Toxicol Appl Pharmacol 139:115–121CrossRefPubMed Wang Z, Templeton DM (1996) Cellular factors mediate cadmium dependent actin depolymerisation. Toxicol Appl Pharmacol 139:115–121CrossRefPubMed
23.
Zurück zum Zitat Apostolava MD, Christova T, Templeton MD (2006) Involvement of Gelsolin in cadmium-induced distruption of the mesengial cell cytoskeleton. Toxicol Sci 89:465–474CrossRef Apostolava MD, Christova T, Templeton MD (2006) Involvement of Gelsolin in cadmium-induced distruption of the mesengial cell cytoskeleton. Toxicol Sci 89:465–474CrossRef
25.
Zurück zum Zitat Akiyama K, Sutoo D, Reid DG (1990) A 1H-NMR comparison of calmodulin activation by calcium and by cadmium. J Pharmacol 53:393–401 Akiyama K, Sutoo D, Reid DG (1990) A 1H-NMR comparison of calmodulin activation by calcium and by cadmium. J Pharmacol 53:393–401
26.
Zurück zum Zitat Kadrmas JL, Beckerle MC (2004) The LIM domain: from the cytoskeleton to the nucleus. Nat Rev Mol Cell Biol 5:920–931CrossRefPubMed Kadrmas JL, Beckerle MC (2004) The LIM domain: from the cytoskeleton to the nucleus. Nat Rev Mol Cell Biol 5:920–931CrossRefPubMed
27.
Zurück zum Zitat Siewit CL, Gengler B, Vegas E, Puckett R, Louie MC (2010) Cadmium promotes breast cancer cell proliferation by potentiating the interaction between ERα and c-Jun. Mol Endocrinol 24(5):981–992PubMedCentralCrossRefPubMed Siewit CL, Gengler B, Vegas E, Puckett R, Louie MC (2010) Cadmium promotes breast cancer cell proliferation by potentiating the interaction between ERα and c-Jun. Mol Endocrinol 24(5):981–992PubMedCentralCrossRefPubMed
28.
Zurück zum Zitat Li J, Sejas DP, Burma S, Chen DJ, Pang Q (2007) Nucleophosmin suppresses oncogene induced apoptosis and and senescence and enhances oncogenic cooperation in cells with genomic instability. Carcinogenesis 28:1163–1170PubMedCentralCrossRefPubMed Li J, Sejas DP, Burma S, Chen DJ, Pang Q (2007) Nucleophosmin suppresses oncogene induced apoptosis and and senescence and enhances oncogenic cooperation in cells with genomic instability. Carcinogenesis 28:1163–1170PubMedCentralCrossRefPubMed
29.
Zurück zum Zitat Beyersmann D, Hechtenberg S (1997) Cadmium, gene regulation, and cellular signalling in mammalian cells. Toxicol Appl Pharmacol 144:247–261CrossRefPubMed Beyersmann D, Hechtenberg S (1997) Cadmium, gene regulation, and cellular signalling in mammalian cells. Toxicol Appl Pharmacol 144:247–261CrossRefPubMed
30.
Zurück zum Zitat Hartmann CA (2006) Wnt cannon orchestrating osteoblastogenesis. Trends Cell Biol 16:151–158CrossRefPubMed Hartmann CA (2006) Wnt cannon orchestrating osteoblastogenesis. Trends Cell Biol 16:151–158CrossRefPubMed
31.
Zurück zum Zitat Li C, Shi X, Zhou G, Liu X, Wu S, Zhao J (2013) The canonical Wnt-β-catenin pathway in development and chemotherapy of osteosarcoma. Front Biosc 18:1384–1391CrossRef Li C, Shi X, Zhou G, Liu X, Wu S, Zhao J (2013) The canonical Wnt-β-catenin pathway in development and chemotherapy of osteosarcoma. Front Biosc 18:1384–1391CrossRef
32.
Zurück zum Zitat Tanimoto A, Hamada T, Koide O (1993) Cell death and regeneration of renal proximal tubular cells in rats with subchronic cadmium intoxication. Toxicol Pathol. 21:341–352CrossRefPubMed Tanimoto A, Hamada T, Koide O (1993) Cell death and regeneration of renal proximal tubular cells in rats with subchronic cadmium intoxication. Toxicol Pathol. 21:341–352CrossRefPubMed
33.
Zurück zum Zitat Brzoska MM, Rogalska J (2013) Protective effect of zinc supplementation against cadmium-induced oxidative stress and the RANK/RANKL/OPG system imbalance in the bone tissue of rats. Toxicol App Pharmacol 272:208–220CrossRef Brzoska MM, Rogalska J (2013) Protective effect of zinc supplementation against cadmium-induced oxidative stress and the RANK/RANKL/OPG system imbalance in the bone tissue of rats. Toxicol App Pharmacol 272:208–220CrossRef
34.
Zurück zum Zitat Long CY, Nusse R (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20:781–810CrossRef Long CY, Nusse R (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20:781–810CrossRef
35.
Zurück zum Zitat Waisberg M, Joseph P, Hale B, Beyersmann D (2003) Molecular and cellular mechanisms of cadmium carcinogenesis. Toxicology 192:95–117CrossRefPubMed Waisberg M, Joseph P, Hale B, Beyersmann D (2003) Molecular and cellular mechanisms of cadmium carcinogenesis. Toxicology 192:95–117CrossRefPubMed
36.
Zurück zum Zitat Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCt method. Methods 25:402–408CrossRefPubMed Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCt method. Methods 25:402–408CrossRefPubMed
37.
Zurück zum Zitat Cantatore FP, Corrado A, Grano M, Quarta L, Colucci S, Melillo N (2004) Osteocalcin synthesis by human osteoblasts from normal and osteoarthritic bone after vitamin D3 stimulation. Clin Rheumatol 23:490–495CrossRefPubMed Cantatore FP, Corrado A, Grano M, Quarta L, Colucci S, Melillo N (2004) Osteocalcin synthesis by human osteoblasts from normal and osteoarthritic bone after vitamin D3 stimulation. Clin Rheumatol 23:490–495CrossRefPubMed
38.
Zurück zum Zitat Devarajan E, Sahin AA, Chen JS, Krishnamurthy RR, Aggarwal N, Brun AM, Sapino A, Zhang F, Sharma D, Yang XH, Tora AD, Mehta K (2002) Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance. Oncogene 21:8843–8851CrossRefPubMed Devarajan E, Sahin AA, Chen JS, Krishnamurthy RR, Aggarwal N, Brun AM, Sapino A, Zhang F, Sharma D, Yang XH, Tora AD, Mehta K (2002) Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance. Oncogene 21:8843–8851CrossRefPubMed
39.
Zurück zum Zitat Templeton DM, Liu Y (2013) Effects of cadmium on the actin cytoskeleton in renal mesangial cells. Can J Physiol Pharmacol 91:1–7CrossRefPubMed Templeton DM, Liu Y (2013) Effects of cadmium on the actin cytoskeleton in renal mesangial cells. Can J Physiol Pharmacol 91:1–7CrossRefPubMed
40.
Zurück zum Zitat Qiu J, Zhu G, Chen X, Shao C, Gu S (2012) Combined effects of γ-irradiation and cadmium exposures on osteoblasts in vitro. Environ Toxicol Pharmacol 33:149–157CrossRefPubMed Qiu J, Zhu G, Chen X, Shao C, Gu S (2012) Combined effects of γ-irradiation and cadmium exposures on osteoblasts in vitro. Environ Toxicol Pharmacol 33:149–157CrossRefPubMed
41.
Zurück zum Zitat Levesque M, Martineau C, Jumarie C, Moreau R (2008) Characterization of cadmium uptake and cytotoxicity in human osteoblast-like MG-63 cells. Toxicol Appl Pharmacol 231:308–317CrossRefPubMed Levesque M, Martineau C, Jumarie C, Moreau R (2008) Characterization of cadmium uptake and cytotoxicity in human osteoblast-like MG-63 cells. Toxicol Appl Pharmacol 231:308–317CrossRefPubMed
42.
Zurück zum Zitat Earnshaw WC, Martins LM, Kaufmann SH (1999) Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68:383–424CrossRefPubMed Earnshaw WC, Martins LM, Kaufmann SH (1999) Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68:383–424CrossRefPubMed
43.
Zurück zum Zitat Riedl SJ, Shi Y (2004) Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5:897–907CrossRefPubMed Riedl SJ, Shi Y (2004) Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5:897–907CrossRefPubMed
44.
Zurück zum Zitat Liu Y, Templeton DM (2010) Role of the cytoskeleton in Cd2+-induced death of mouse mesangial cells. Can J Physiol Pharmacol 88:341–352CrossRefPubMed Liu Y, Templeton DM (2010) Role of the cytoskeleton in Cd2+-induced death of mouse mesangial cells. Can J Physiol Pharmacol 88:341–352CrossRefPubMed
45.
Zurück zum Zitat Martini FH, Timmons MJ (1997) Human Anatomy, 2nd edn. Prentice Hall, New Jersey, pp 25–48 Martini FH, Timmons MJ (1997) Human Anatomy, 2nd edn. Prentice Hall, New Jersey, pp 25–48
46.
Zurück zum Zitat Schneider N, Weber I, Faix J, Prassler J, Müller-Taubenberger A, Köhler J, Burghardt E, Gerisch G, Marriott G (2003) A Lim protein involved in the progression of cytokinesis and regulation of the mitotic spindle. Cell Motil Cytoskeleton 56:130–139CrossRefPubMed Schneider N, Weber I, Faix J, Prassler J, Müller-Taubenberger A, Köhler J, Burghardt E, Gerisch G, Marriott G (2003) A Lim protein involved in the progression of cytokinesis and regulation of the mitotic spindle. Cell Motil Cytoskeleton 56:130–139CrossRefPubMed
47.
Zurück zum Zitat Pollard TD, Borisy GG (2003) Cellular motility driven by assembly and disassembly of actin filaments. Cell 112:453–465CrossRefPubMed Pollard TD, Borisy GG (2003) Cellular motility driven by assembly and disassembly of actin filaments. Cell 112:453–465CrossRefPubMed
48.
Zurück zum Zitat Schmeichel KL, Beckerle MC (1994) The LIM domain is a modularprotein binding interface. Cell 79:211–219CrossRefPubMed Schmeichel KL, Beckerle MC (1994) The LIM domain is a modularprotein binding interface. Cell 79:211–219CrossRefPubMed
49.
Zurück zum Zitat Brun J, Dieudonné FX, Marty C, Müller J, Schüle R, Patiño-García A, Lecanda F, Fromigué O, Marie PJ (2013) FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo. PLoS One. 8:e55034. doi: 10.1371 Brun J, Dieudonné FX, Marty C, Müller J, Schüle R, Patiño-García A, Lecanda F, Fromigué O, Marie PJ (2013) FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo. PLoS One. 8:e55034. doi: 10.1371
50.
Zurück zum Zitat Chen X, Zhu G, Jin T, Zhou Z, Gu S, Qiu J, Xiao H (2012) Cadmium stimulates the osteoclastic differentiation of RAW264.7 cells in presence of osteoblasts. Biol Trace Elem Res 146:349–353CrossRefPubMed Chen X, Zhu G, Jin T, Zhou Z, Gu S, Qiu J, Xiao H (2012) Cadmium stimulates the osteoclastic differentiation of RAW264.7 cells in presence of osteoblasts. Biol Trace Elem Res 146:349–353CrossRefPubMed
Metadaten
Titel
The endocrine disruptor cadmium alters human osteoblast-like Saos-2 cells homeostasis in vitro by alteration of Wnt/β-catenin pathway and activation of caspases
verfasst von
V. Papa
V. M. Bimonte
F. Wannenes
A. S. D’Abusco
S. Fittipaldi
R. Scandurra
L. Politi
C. Crescioli
A. Lenzi
L. Di Luigi
S. Migliaccio
Publikationsdatum
01.12.2015
Verlag
Springer International Publishing
Erschienen in
Journal of Endocrinological Investigation / Ausgabe 12/2015
Elektronische ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-015-0380-x

Weitere Artikel der Ausgabe 12/2015

Journal of Endocrinological Investigation 12/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.